Return to Today's science sparks archives

2010-07-01

Fig 1. Hierarchical unsupervised clustering was performed using Partek® Genomics SuiteTM across all genes present on the Affymetrix U133A chip.

Fig 1. Hierarchical unsupervised clustering was performed using Partek® Genomics SuiteTM across all genes present on the Affymetrix U133A chip.
  • Hajdu M, Singer S, Maki RG, Schwartz GK, Keohan ML, Antonescu CR

  • J Pathol. 2010 Jul;221(3):300-7.

2010-07-02

Fig 1f. Representative immunofluorescence images of normal primary TH1-differentiating cells.

Fig 1f. Representative immunofluorescence images of normal primary TH1-differentiating cells.
  • Taylor MD, Sadhukhan S, Kottangada P, Ramgopal A, Sarkar K, D'Silva S, Selvakumar A, Candotti F, Vyas YM

  • Sci Transl Med. 2010 Jun 23;2(37):37ra44.

2010-07-06

Fig 1. ORTEP diagram for compound 41.

Fig 1. ORTEP diagram for compound 41.
  • Trzupek JD, Lee D, Crowley BM, Marathias VM, Danishefsky SJ

  • J Am Chem Soc. 2010 Jun 23;132(24):8506-12.

2010-07-07

Fig 1. Models for TopIB-Mediated DNA Synapsis.

Fig 1. Models for TopIB-Mediated DNA Synapsis.
  • Patel A, Yakovleva L, Shuman S, Mondragón A

  • Structure. 2010 Jun 9;18(6):725-33.

2010-07-08

Fig 1. The structure of the WT-1 gene and the WT-1 protein, with mapping of reported peptide epitopes presented by class I or II HLA alleles.

Fig 1. The structure of the WT-1 gene and the WT-1 protein, with mapping of reported peptide epitopes presented by class I or II HLA alleles.
  • O'Reilly RJ, Dao T, Koehne G, Scheinberg D, Doubrovina E

  • Semin Immunol. 2010 Jun;22(3):162-72.

2010-07-09

Fig 1. Lesion at L1. The gross target volume is shown in light blue. The clinical target volume (orange) encompasses the vertebral body.

Fig 1. Lesion at L1. The gross target volume is shown in light blue. The clinical target volume (orange) encompasses the vertebral body.
  • Lovelock DM, Zhang Z, Jackson A, Keam J, Bekelman J, Bilsky M, Lis E, Yamada Y

  • Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1282-1287.

2010-07-12

Fig 5. Transverse (top row) and sagittal (bottom row) dose distributions from the Coll-volumetric modulated arc therapy (VMAT), standard VMAT, and intensity-modulated radiation therapy (IMRT) plans of the patient with a 273-cc planning target volume (PTV). The PTV is shown in yellow and the cord in blue.

Fig 5. Transverse (top row) and sagittal (bottom row) dose distributions from the Coll-volumetric modulated arc therapy (VMAT), standard VMAT, and intensity-modulated radiation therapy (IMRT) plans of the patient with a 273-cc planning target volume (PTV). The PTV is shown in yellow and the cord in blue.
  • Zhang P, Happersett L, Yang Y, Yamada Y, Mageras G, Hunt M

  • nt J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):591-9.

2010-07-13

Graphical Abstract. Fate of T-cells bearing high-affinity TCRs to self-antigens in the presence or absence of TGF-beta signaling.

Graphical Abstract. Fate of T-cells bearing high-affinity TCRs to self-antigens in the presence or absence of TGF-beta signaling.
  • Ouyang W, Beckett O, Ma Q, Li MO

  • Immunity. 2010 May 28;32(5):642-53.

2010-07-14

Fig 1. IC CXPA, MC type. Patient presented with metastasis to the contralateral temporal soft tissue at the time of diagnosis. The tumor was entirely submitted for histologic examination.

Fig 1. IC CXPA, MC type. Patient presented with metastasis to the contralateral temporal soft tissue at the time of diagnosis. The tumor was entirely submitted for histologic examination.
  • Katabi N, Gomez D, Klimstra DS, Carlson DL, Lee N, Ghossein R

  • Hum Pathol. 2010 Jul;41(7):927-34.

2010-07-15

Fig 1. Topical lidocaine and opioid analagesia.

Fig 1. Topical lidocaine and opioid analagesia.
  • Kolesnikov YA, Oksman G, Pasternak GW

  • Eur J Pharmacol. 2010 Jul 25;638(1-3):61-4.

2010-07-16

Fig 4. p27, Bad and Bax gene expression analysis with or without AG1478 assayed by QRT-PCR.

Fig 4. p27, Bad and Bax gene expression analysis with or without AG1478 assayed by QRT-PCR.
  • Ayuso-Sacido A, Moliterno JA, Kratovac S, Kapoor GS, O'Rourke DM, Holland EC, García-Verdugo JM, Roy NS, Boockvar JA

  • J Neurooncol. 2010 May;97(3):323-37.

2010-07-19

Fig 1. PSM surgical learning curve in patients with typical cancer severity. A, predicted probability (black curve) and 95% CI (gray curves) of PSM by increasing surgical experience.

Fig 1. PSM surgical learning curve in patients with typical cancer severity. A, predicted probability (black curve) and 95% CI (gray curves) of PSM by increasing surgical experience.
  • Vickers A, Bianco F, Cronin A, Eastham J, Klein E, Kattan M, Scardino P

  • J Urol. 2010 Apr;183(4):1360-5.

2010-07-20

Fig 1. Memorial Sloan-Kettering Cancer Center approaches and outcomes in patients with locoregional and metastatic neuroblastoma.

Fig 1. Memorial Sloan-Kettering Cancer Center approaches and outcomes in patients with locoregional and metastatic neuroblastoma.
  • Modak S, Cheung NK

  • Cancer Treat Rev. 2010 Jun;36(4):307-17.

2010-07-21

Fig 2a. Normal lung parenchyma with a few alveolar macrophages.

Fig 2a. Normal lung parenchyma with a few alveolar macrophages.
  • Ihekweazu UN, Travis WD, Flores RM

  • J Thorac Cardiovasc Surg. 2010 Jul;140(1):242-3.

2010-07-22

Fig 3a. Relapsed metastatic NB in a patient who remains progression-free, now 74+ months since detection of CNS disease.

Fig 3a. Relapsed metastatic NB in a patient who remains progression-free, now 74+ months since detection of CNS disease.
  • Kramer K, Kushner BH, Modak S, Pandit-Taskar N, Smith-Jones P, Zanzonico P, Humm JL, Xu H, Wolden SL, Souweidane MM, Larson SM, Cheung NK

  • J Neurooncol. 2010 May;97(3):409-18.

2010-07-26

Fig 1. Representative hematoxylin and eosin sections of cHL cases that showed an increase in TIA-1+ cells and decrease of FOXP3+ cells.

Fig 1. Representative hematoxylin and eosin sections of cHL cases that showed an increase in TIA-1+ cells and decrease of FOXP3+ cells.
  • Koreishi AF, Saenz AJ, Persky DO, Cui H, Moskowitz A, Moskowitz CH, Teruya-Feldstein J

  • Appl Immunohistochem Mol Morphol. 2010 May;18(3):206-11.

2010-07-27

Fig 3. Images of egg chambers stained with DAPI (4',6'-diamidino-2-phenylindole) from indicated genotypes. Red stars mark individual nurse cell nuclei.

Fig 3. Images of egg chambers stained with DAPI (4',6'-diamidino-2-phenylindole) from indicated genotypes. Red stars mark individual nurse cell nuclei.
  • Lu WJ, Chapo J, Roig I, Abrams JM

  • Science. 2010 Jun 4;328(5983):1278-81.

2010-07-28

Fig 2. (A) Crystal structure of geldanamycin (3) bound to Hsp90; solid-state trans-amide (B) and protein-bound cis-amide (C) conformations of geldanamycin (3) (see ref 6b).

Fig 2. (A) Crystal structure of geldanamycin (3) bound to Hsp90; solid-state trans-amide (B) and protein-bound cis-amide (C) conformations of geldanamycin (3) (see ref 6b).
  • Wrona IE, Gozman A, Taldone T, Chiosis G, Panek JS

  • J Org Chem. 2010 May 7;75(9):2820-35.

2010-07-29

Fig 2c. Axial MR image showing high-grade ESCC caused by tumor recurrence.

Fig 2c. Axial MR image showing high-grade ESCC caused by tumor recurrence.
  • Laufer I, Hanover A, Lis E, Yamada Y, Bilsky M

  • J Neurosurg Spine. 2010 Jul;13(1):109-15.

2010-07-30

Fig 1. As the gatekeeper of the cell, p53 acts as a negative regulator of cellular proliferation.

Fig 1. As the gatekeeper of the cell, p53 acts as a negative regulator of cellular proliferation.
  • D’Angelo S, Pietanza M

  • Cancer Biol Ther. 2010 Jul 1;10(1):1-10.

2010-08-02

Fig 6. Model for the Architecture of the COPI Lattice.

Fig 6. Model for the Architecture of the COPI Lattice.
  • Lee C, Goldberg J

  • Cell. 2010 Jul 9;142(1):123-32.

2010-08-03

Fig 2. Ceramide-rich platforms in murine tracheal epithelial cells following in vivo infection with Pseudomonas aeruginosa.

Fig 2. Ceramide-rich platforms in murine tracheal epithelial cells following in vivo infection with Pseudomonas aeruginosa.
  • Stancevic B, Kolesnick R

  • FEBS Lett. 2010 May 3;584(9):1728-40.

2010-08-04

Fig 2. The cytosine methylation levels of 97 primary CRC and 64 matched normal mucosas were profiled using bisulfite/PCR/LDR/Universal Array assay.

Fig 2. The cytosine methylation levels of 97 primary CRC and 64 matched normal mucosas were profiled using bisulfite/PCR/LDR/Universal Array assay.
  • Cheng YW, Idrees K, Shattock R, Khan SA, Zeng Z, Brennan CW, Paty P, Barany F

  • Int J Cancer. 2010 Aug 1;127(3):568-77.

2010-08-05

Fig 5. In vitro blockage of SPARC results in decrease of bladder cancer cell motility.

Fig 5. In vitro blockage of SPARC results in decrease of bladder cancer cell motility.
  • Makridakis M, Roubelakis MG, Bitsika V, Dimuccio V, Samiotaki M, Kossida S, Panayotou G, Coleman J, Candiano G, Anagnou NP, Vlahou A

  • J Proteome Res. 2010 May 13;9(6):3243–59.

2010-08-06

Fig 1. Principal component analysis of 20 structural and physicochemical descriptors of the 40 top-selling drugs, 60 diverse natural products, 20 polycyclic alkaloids and terpenoids, 20 ChemBridge and Chem Div library members, and 32 multiscaffold library members.

Fig 1. Principal component analysis of 20 structural and physicochemical descriptors of the 40 top-selling drugs, 60 diverse natural products, 20 polycyclic alkaloids and terpenoids, 20 ChemBridge and Chem Div library members, and 32 multiscaffold library members.
  • Bauer RA, DiBlasi CM, Tan DS

  • Org Lett. 2010 May 7;12(9):2084-7.

2010-08-09

Fig 2a. Site of first systemic relapses in patients with initial diagnosis of melanoma substage IIIA.

Fig 2a. Site of first systemic relapses in patients with initial diagnosis of melanoma substage IIIA.
  • Romano E, Scordo M, Dusza SW, Coit DG, Chapman PB

  • J Clin Oncol. 2010 Jun 20;28(18):3042-7.

2010-08-10

Fig 2. Deletion of the Spt5 CTD results in aberrant cell morphology.

Fig 2. Deletion of the Spt5 CTD results in aberrant cell morphology.
  • Schneider S, Pei Y, Shuman S, Schwer B

  • Mol Cell Biol. 2010 May;30(10):2353-64.

2010-08-11

Fig 1b. Histologic features of a colonic tumor (B, H&E, ×200) from a patient with a history suggestive of hereditary nonpolyposis colorectal cancer/Lynch syndrome.

Fig 1b. Histologic features of a colonic tumor (B, H&E, ×200) from a patient with a history suggestive of hereditary nonpolyposis colorectal cancer/Lynch syndrome.
  • Agaram NP, Shia J, Tang LH, Klimstra DS

  • Am J Clin Pathol. 2010 May;133(5):772-80.

2010-08-12

Fig 2. Cell lineage relationships in the early mouse embryo.

Fig 2. Cell lineage relationships in the early mouse embryo.
  • Nowotschin S, Hadjantonakis AK

  • Curr Opin Genet Dev. 2010 Aug;20(4):420-7.

2010-08-13

Fig 1b.  Phantom images recorded using PET of 6 samples of 89Zr activity in water.

Fig 1b. Phantom images recorded using PET of 6 samples of 89Zr activity in water.
  • Ruggiero A, Holland JP, Lewis JS, Grimm J

  • J Nucl Med. 2010 Jul;51(7):1123-30.

2010-08-16

Fig 3. A 3-year-old male patient with neuroblastoma in remission.

Fig 3. A 3-year-old male patient with neuroblastoma in remission.
  • D'Ambrosio N, Lyo J, Young R, Haque S, Karimi S

  • Neuroradiology. 2010 Jun;52(6):549-53.

2010-08-17

Fig 2. Kaplan-Meier curves of disease-free survival stratified by (A) Beyer risk group classification, (B) Beyer raw score, (C) Einhorn risk group classification, and (D) Einhorn risk classification with the low- and intermediate-risk cohorts combined into one group.

Fig 2. Kaplan-Meier curves of disease-free survival stratified by (A) Beyer risk group classification, (B) Beyer raw score, (C) Einhorn risk group classification, and (D) Einhorn risk classification with the low- and intermediate-risk cohorts combined into one group.
  • Feldman DR, Sheinfeld J, Bajorin DF, Fischer P, Turkula S, Ishill N, Patil S, Bains M, Reich LM, Bosl GJ, Motzer RJ

  • J Clin Oncol. 2010 Apr 1;28(10):1706-13.

2010-08-18

Fig 1. Schematic representation of the localizations of proteins that regulate spindle positioning in the single-cell embryo.

Fig 1. Schematic representation of the localizations of proteins that regulate spindle positioning in the single-cell embryo.
  • Krueger LE, Wu JC, Tsou MF, Rose LS

  • J Cell Biol. 2010 May 3;189(3):481-95.

2010-08-19

Fig 1. Contrast-enhanced neck CT scans (a, c) and CT perfusion maps (b, d) of a 45-year-old man with stage IV (a–b) and a 57-year-old woman with stage III (c–d) HNSCC in the base of the tongue.

Fig 1. Contrast-enhanced neck CT scans (a, c) and CT perfusion maps (b, d) of a 45-year-old man with stage IV (a–b) and a 57-year-old woman with stage III (c–d) HNSCC in the base of the tongue.
  • Jansen JF, Koutcher JA, Shukla-Dave A

  • Angiogenesis. 2010 Jun;13(2):149-60.

2010-08-20

Fig 1a. High-resolution melting (HRM) normalized and temperature-shifted difference plot for IDH1 and IDH2.

Fig 1a. High-resolution melting (HRM) normalized and temperature-shifted difference plot for IDH1 and IDH2.
  • Tefferi A, Lasho TL, Abdel-Wahab O, Guglielmelli P, Patel J, Caramazza D, Pieri L, Finke CM, Kilpivaara O, Wadleigh M, Mai M, McClure RF, Gilliland DG, Levine RL, Pardanani A, Vannucchi AM

  • Leukemia. 2010 Jul;24(7):1302-9.

2010-08-23

Fig 1. Magnetic resonance imaging (MRI) and 18F-fluoromisonidazole (18F-FMISO) positron emission tomography (PET) images illustrating the hypoxic right neck lymph node of Patient 2 (male, 62 years old, primary tonsil cancer).

Fig 1. Magnetic resonance imaging (MRI) and 18F-fluoromisonidazole (18F-FMISO) positron emission tomography (PET) images illustrating the hypoxic right neck lymph node of Patient 2 (male, 62 years old, primary tonsil cancer).
  • Jansen JF, Schöder H, Lee NY, Wang Y, Pfister DG, Fury MG, Stambuk HE, Humm JL, Koutcher JA, Shukla-Dave A

  • Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1403-10.

2010-08-25

Chart 1. Chemical structure of N-mustard derivatives.

Chart 1. Chemical structure of N-mustard derivatives.
  • Kakadiya R, Dong H, Kumar A, Narsinh D, Zhang X, Chou TC, Lee TC, Shah A, Su TL

  • Bioorg Med Chem. 2010 Mar 15;18(6):2285-99.

2010-08-26

Fig 3. Left ventricular ejection fraction (LVEF) results. AC, doxorubicin plus cyclophosphamide; PTL, paclitaxel plus trastuzumab plus lapatinib; TL, trastuzumab plus lapatinib.

Fig 3. Left ventricular ejection fraction (LVEF) results. AC, doxorubicin plus cyclophosphamide; PTL, paclitaxel plus trastuzumab plus lapatinib; TL, trastuzumab plus lapatinib.
  • Dang C, Lin N, Moy B, Come S, Sugarman S, Morris P, Abbruzzi A, Chen C, Steingart R, Patil S, Norton L, Winer E, Hudis C

  • J Clin Oncol. 2010 Jun 20;28(18):2982-8.

2010-08-27

Fig 1. Ovarian tumor tissue microarray immunohistochemical staining of B7-H3. B7-H3 expression is shown in serous cell carcinoma and tumor vessels (a, × 200), in clear cell carcinoma and tumor vessels.

Fig 1. Ovarian tumor tissue microarray immunohistochemical staining of B7-H3. B7-H3 expression is shown in serous cell carcinoma and tumor vessels (a, × 200), in clear cell carcinoma and tumor vessels.
  • Zang X, Sullivan PS, Soslow RA, Waitz R, Reuter VE, Wilton A, Thaler HT, Arul M, Slovin SF, Wei J, Spriggs DR, Dupont J, Allison JP

  • Mod Pathol. 2010 Aug;23(8):1104-12.

2010-08-30

Fig 2. Survival of patients following diagnosis of leptomeningeal metastasis by tumor type.

Fig 2. Survival of patients following diagnosis of leptomeningeal metastasis by tumor type.
  • Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM

  • Neurology. 2010 May 4;74(18):1449-54.

2010-08-31

Fig 1. Reported molecular markers more commonly associated with particular histologic sub-types.

Fig 1. Reported molecular markers more commonly associated with particular histologic sub-types.
  • Power DG, Kelsen DP, Shah MA

  • Cancer Treat Rev. 2010 Aug;36(5):384-92.

2010-09-01

Fig 2d. Enhancing image contrast with DSLM-SI.Maximum-intensity projections of a DSLM time-lapse recording of a membrane- and nuclei-labeled zebrafish embryo injected with ras-eGFP mRNA and H2A-mCherry mRNA at the one-cell stage.

Fig 2d. Enhancing image contrast with DSLM-SI.Maximum-intensity projections of a DSLM time-lapse recording of a membrane- and nuclei-labeled zebrafish embryo injected with ras-eGFP mRNA and H2A-mCherry mRNA at the one-cell stage.
  • Keller PJ, Schmidt AD, Santella A, Khairy K, Bao Z, Wittbrodt J, Stelzer EH

  • Nat Methods. 2010 Aug;7(8):637-42.

2010-09-02

Fig 12. On histopathologic analysis, desmoplastic trichoepithelioma is composed of narrow strands of basaloid aggregates (*), horn cysts, and a sclerosing stroma (**) separated by clefts (arrows) from the dermis. In a trichoepithelioma, the basaloid cell aggregates are larger and well circumscribed.

Fig 12. On histopathologic analysis, desmoplastic trichoepithelioma is composed of narrow strands of basaloid aggregates (*), horn cysts, and a sclerosing stroma (**) separated by clefts (arrows) from the dermis. In a trichoepithelioma, the basaloid cell aggregates are larger and well circumscribed.
  • Lee EH, Nehal KS, Disa JJ

  • Plast Reconstr Surg. 2010 May;125(5):188e-198e.

2010-09-03

Fig 2b. Preoperative MRI reveals error in anatomy/position in patient with 4 cm multiloculated, thick UD spanning entire urethral length. MRI shows 2 cm C-shaped UD distal to bladder neck.

Fig 2b. Preoperative MRI reveals error in anatomy/position in patient with 4 cm multiloculated, thick UD spanning entire urethral length. MRI shows 2 cm C-shaped UD distal to bladder neck.
  • Chung DE, Purohit RS, Girshman J, Blaivas JG

  • J Urol. 2010 Jun;183(6):2265-9.

2010-09-07

Fig 4. Clinical outcomes based on the site of RAI metastatic disease.

Fig 4. Clinical outcomes based on the site of RAI metastatic disease.
  • Tuttle RM, Lopez N, Leboeuf R, Minkowitz SM, Grewal R, Brokhin M, Omry G, Larson S

  • Thyroid. 2010 Mar;20(3):257-63.

2010-09-08

Fig 10F. KIF17 participates in epithelial cystogenesis. Tyrosinated tubulin, acetylated tubulin, and DAPI staining in mature control cyst.

Fig 10F. KIF17 participates in epithelial cystogenesis. Tyrosinated tubulin, acetylated tubulin, and DAPI staining in mature control cyst.
  • Jaulin F, Kreitzer G

  • J Cell Biol. 2010 Aug 9;190(3):443-60.

2010-09-09

Fig 4a. Identification of MBOAT Homology Regions.

Fig 4a. Identification of MBOAT Homology Regions.
  • Buglino JA, Resh MD

  • PLoS One. 2010 Jun 23;5(6):e11195.
Open Access button

2010-09-10

Fig 10. Eosinophils and neutrophils are essential for efficient clearance of apoptotic thymocytes.

Fig 10. Eosinophils and neutrophils are essential for efficient clearance of apoptotic thymocytes.
  • Kim HJ, Alonzo ES, Dorothee G, Pollard JW, Sant'Angelo DB

  • PLoS One. 2010 Jul 6;5(7):e11439.

2010-09-13

Fig 2. DNA Topology and Its Relevance in Transcription and Replication.

Fig 2. DNA Topology and Its Relevance in Transcription and Replication.
  • Koster DA, Crut A, Shuman S, Bjornsti MA, Dekker NH

  • Cell. 2010 Aug 20;142(4):519-30.

2010-09-14

Fig. 1. Competition between double-strand break repair pathways

Fig. 1. Competition between double-strand break repair pathways
  • Kass EM, Jasin M

  • FEBS Lett. 2010 Sep 10;584(17):3703-8.

2010-09-15

Fig 2A. Genetic inducible fate mapping.

Fig 2A. Genetic inducible fate mapping.
  • Legué E, Joyner AL.

  • Methods Enzymol. 2010;477:153-81.

2010-09-16

Fig 1. Diverted total synthesis (DTS).

Fig 1. Diverted total synthesis (DTS).
  • Wilson RM, Danishefsky SJ

  • Angew Chem Int Ed Engl. 2010 Aug 16;49(35):6032-56.

2010-09-17

Fig 2. Overall structure of the EphA4 LBD. The two molecules found in the asymmetric unit are superimposed. The A chain is shown in green and the B chain in cyan.

Fig 2. Overall structure of the EphA4 LBD. The two molecules found in the asymmetric unit are superimposed. The A chain is shown in green and the B chain in cyan.
  • Singla N, Goldgur Y, Xu K, Paavilainen S, Nikolov DB, Himanen JP

  • Biochem Biophys Res Commun. 2010 Sep 3;399(4):555-9.

2010-09-20

Fig 1b. Infiltrative follicular variant of papillary thyroid carcinoma.Medium power showing tongues of tumor-infiltrating non-neoplastic thyroid without interposition of a capsule (arrow).

Fig 1b. Infiltrative follicular variant of papillary thyroid carcinoma.Medium power showing tongues of tumor-infiltrating non-neoplastic thyroid without interposition of a capsule (arrow).
  • Rivera M, Ricarte-Filho J, Knauf J, Shaha A, Tuttle M, Fagin JA, Ghossein RA

  • Mod Pathol. 2010 Sep;23(9):1191-200.

2010-09-21

Fig 1. Cdc42 regulates tight junction formation in 16HBE cells. 16HBE cells were seeded at low density on glass coverslips and transfected with the indicated siRNA. (A) Three days after transfection cells were fixed and analyzed by immunofluorescence microscopy with anti-occludin (green) and Hoechst (blue). Scale bar, 20 µm in all images.

Fig 1. Cdc42 regulates tight junction formation in 16HBE cells. 16HBE cells were seeded at low density on glass coverslips and transfected with the indicated siRNA. (A) Three days after transfection cells were fixed and analyzed by immunofluorescence microscopy with anti-occludin (green) and Hoechst (blue). Scale bar, 20 µm in all images.
  • Wallace SW, Durgan J, Jin D, Hall A

  • Mol Biol Cell. 2010 Sep;21(17):2996-3006.

2010-09-22

Fig 1. Pediatric malignant gliomas exhibiting positive (left) and negative (right) staining for pAkt

Fig 1. Pediatric malignant gliomas exhibiting positive (left) and negative (right) staining for pAkt
  • Pollack IF, Hamilton RL, Burger PC, Brat DJ, Rosenblum MK, Murdoch GH, Nikiforova MN, Holmes EJ, Zhou T, Cohen KJ, Jakacki RI; Children's Oncology Group

  • J Neurooncol. 2010 Sep;99(2):155-63.

2010-09-24

Fig 7. Live imaging of postimplantation mouse development, visualization of mesoderm cell dynamics during foregut invagination.

Fig 7. Live imaging of postimplantation mouse development, visualization of mesoderm cell dynamics during foregut invagination.
  • Nowotschin S, Ferrer-Vaquer A, Hadjantonakis AK

  • Methods Enzymol. 2010;476:351-77.

2010-09-27

Fig 3. Kaplan-Meier survival curves for 432 lung adenocarcinomas (AD) showing a significant difference between clusters (log-rank test: p = 0.000194).

Fig 3. Kaplan-Meier survival curves for 432 lung adenocarcinomas (AD) showing a significant difference between clusters (log-rank test: p = 0.000194).
  • Bryant CM, Albertus DL, Kim S, Chen G, Brambilla C, Guedj M, Arima C, Travis WD, Yatabe Y, Takahashi T, Brambilla E, Beer DG

  • PLoS One. 2010 Jul 22;5(7):e11712.

2010-09-28

Fig 2a. Gadolinium-enhanced brain MRI at diagnosis of LM (a, arrows).

Fig 2a. Gadolinium-enhanced brain MRI at diagnosis of LM (a, arrows).
  • Clarke JL, Pao W, Wu N, Miller VA, Lassman AB

  • J Neurooncol. 2010 Sep;99(2):283-6.

2010-09-29

Fig 1. Examples of fibrolamellar carcinoma.

Fig 1. Examples of fibrolamellar carcinoma.
  • Ward SC, Huang J, Tickoo SK, Thung SN, Ladanyi M, Klimstra DS

  • Mod Pathol. 2010 Sep;23(9):1180-90.

2010-09-30

Fig 2. Effects of biopsy scheme. ProtecT (10 cores) versus ERSPC Göteborg and Rotterdam (6 cores).

Fig 2. Effects of biopsy scheme. ProtecT (10 cores) versus ERSPC Göteborg and Rotterdam (6 cores).
  • Vickers AJ, Cronin AM, Roobol MJ, Hugosson J, Jones JS, Kattan MW, Klein E, Hamdy F, Neal D, Donovan J, Parekh DJ, Ankerst D, Bartsch G, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Freedland SJ, Moreira DM, Schröder FH, Lilja H

  • Clin Cancer Res. 2010 Sep 1;16(17):4374-81.

2010-10-01

Fig 5.  HT29 tumor sections showing blood perfusion, in vivo targeting of CAIX by 111In-DOTA-Fab-cG250 and endogenous CAIX expression at 24 hours pi.

Fig 5. HT29 tumor sections showing blood perfusion, in vivo targeting of CAIX by 111In-DOTA-Fab-cG250 and endogenous CAIX expression at 24 hours pi.
  • Carlin S, Khan N, Ku T, Longo VA, Larson SM, Smith-Jones PM

  • PLoS One. 2010 May 27;5(5):e10857.
Open Access button